Stay up-to-date with the latest Sciety news

Discover the latest updates on our company and investments in life science

Sciety news

Cartana is acquired by 10x Genomics for 425 MSEK


PRESS RELEASE. The American biotechnology company 10x Genomics acquires the Swedish company Cartana, which was financed by the Sciety investment syndicate two years ago. Three years after launch, the Swedish biotechnology company Cartana will be part of the Nasdaq-listed American company 10x Genomics––the market leader in single-cell analysis technology. The…

Read more

Interview with Mats Nilsson, serial entrepreneur at SciLifeLab


Sciety had the opportunity to ask a few questions to Mats Nilsson, professor at SciLifeLab and co-founder of EMPE Diagnostics and several other biotechnology companies. In the interview he talks about EMPE Diagnostics’ planned establishment in India and and about the need for diagnostic tools in order to use the drugs that are available. He gives an insight into SciLifeLab as the platform for developing ideas and also his view on the role of research in society.

Read more

The Sciety syndicate invests in Synartro that develops a novel drug for osteoarthritis


The Sciety syndicate invests in Synartro, which uses existing drugs with proven efficacy to develop an improved drug treatment of knee osteoarthritis. The new capital will be used to complete the pre-clinical development. The company plans to go public to raise capital for phase 1 clinical trials in 2021. Synartro’s…

Read more

Interview with Pavan Asalapuram, co-founder of EMPE Diagnostics


Sciety talks with Pavan Asalapuram, co-founder of EMPE Diagnostics, a company that develops rapid diagnostic solutions for infectious diseases, with a special focus on tuberculosis––a major public health problem in big parts of the world. EMPE’s test can within two hours identify whether a person has TB and whether it…

Read more

The Sciety syndicate invests MSEK 9.1 in a cardiovascular diagnostic company


The Sciety investment syndicate recently made an investment of 9.1 million SEK in the company Cavis Technologies, which has developed Wirecath®––a patent-pending product for the diagnosis of coronary heart diseases. The new capital will be used to establish sales on the European market. “Only in Europe, over 1.5 million people…

Read more

New diagnostic technology can reduce mortality in one of the world’s most common infectious diseases


Today, Sciety wants to pay attention to World TB Day, which aims to highlight the extensive health, social and economic consequences of tuberculosis. Tuberculosis is a contagious infectious disease that primarily affects the lungs but also other organs. It is an airborne disease that spreads when a person with tuberculosis…

Read more

New technology can contribute to safer diagnoses of diseases of the coronary heart


One of the most common causes of death in the world comes from diseases of the coronary arteries, the heart’s own blood vessels. Coronary artery disease occurs through constriction of the coronary arteries that leads to a pressure drop which can cause heart attack and stroke. Diseases of the coronary…

Read more

Sciety invests in cancer diagnostics of the future with Industrifonden


Sciety invests SEK 35 million in the company Elypta, which is developing a new method for early cancer diagnosis. The Sciety network together with the Swedish venture capital fund Industrifonden, Chalmers Ventures and several of the company’s existing owners took part in the capitalization. The new capital of a total…

Read more

Sciety network invests in Predicare, the company that aims to streamline emergency care around the world


The Sciety investment syndicate recently completed an investment of MSEK 9 in Predicare, a company that has developed RETTS––a system used by the majority of Sweden’s emergency units. The new capital will be used to expand in selected European markets and further develop the company’s product portfolio. Gothenburg-based Predicare was…

Read more

Predicare is growing––new customers in Norway


During September, Predicare finalised an agreement with two new clients in Norway––a hospital and an ambulance services company. Predicare continues to grow rapidly in Norway and their RETTS© system is used by 31 out of 49 hospitals with emergency units. CEO, Mathias Myrén, says: “Predicare has signed an agreement with…

Read more